DVA vs. CHE: Which Stock Is the Better Value Option?
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"). The 2030 notes were priced at 100% of their face amount to yield a 4.625% coupon. The offering is expected to close on June 9, 2020, subject to satisfaction of customary closing conditions.
DaVita's (DVA) dialysis services in the United States showcased solid results in Q1.
Hyatt Hotels jumps on financial results Continue reading...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Image source: The Motley Fool. DaVita (NYSE: DVA)Q1 2020 Earnings CallMay 05, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, good evening.
Canadian guru releases portfolio. Sells include major Berkshire bank holding Bank of America. Continue reading...
Moody's Investors Service ("Moody's") announced today that it assigned a Ba3 rating to DaVita Inc.'s ("DaVita") proposed senior unsecured global notes due 2030. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, Ba1 senior secured rating, and Ba3 unsecured rating.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is (DVA) Outperforming Other Medical Stocks This Year?
PEG-based investing can be more rewarding with the addition of a few other relevant parameters amid coronavirus-led market rattle.
Q1 2020 DaVita Inc Earnings Call
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 25.34% and 0.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
DVA vs. CHE: Which Stock Is the Better Value Option?
Warren Buffett fans are always eager to see which stocks Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is buying and selling. On May 15, Berkshire released its latest 13F form, which shows the company's holdings as of the end of March 31 -- after the markets crashed. Like many investors, Berkshire was selling many of its stocks.
For Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) shareholders and fans of Warren Buffett, the previous weekend was the most-anticipated event of the year. On Saturday, May 2, Buffett held his company's annual shareholder meeting (albeit virtually) and provided the usual dose of long-term wisdom that investors look for.
Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...
DaVita Kidney Care recently announced its continued support for U.S. employees, known as teammates, during the COVID-19 pandemic by implementing and strengthening programs specifically created to meet the emerging needs of teammates based on their ongoing feedback.
Dialysis is the process of using a medical circulation device (either at home or at a clinic) to substitute kidney functions for patients with end-stage kidney failure. Each year, over 100,000 Americans with new cases of renal failure visit dialysis clinics to receive appropriate treatment. Since the full cost of dialysis treatments is reimbursed by the U.S. government, a wave of providers has moved to capitalize on the opportunity.
DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"), subject to market and other conditions.